Patents by Inventor Whe-Yong Lo

Whe-Yong Lo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
    Patent number: 6500457
    Abstract: Novel pharmaceutical dosage forms provide for pulsatile delivery of an antiarrhythmic agent that releases the drug in spaced apart “pulses.” The dosage forms are comprised of first, second and optional third dosage units, with each dosage unit having a different drug release profile. The dosage forms may comprise capsules housing compressed tablets or drug-containing beads, granules, or particles or may comprise a single tablet with the first, second and optional third dosage units incorporated therein, or a “coated core” dosage form. Methods of treatment using the pharmaceutical dosage forms are provided as well.
    Type: Grant
    Filed: August 14, 2000
    Date of Patent: December 31, 2002
    Assignee: Peirce Management, LLC
    Inventors: Kamal K. Midha, Mark Hirsh, Whe-Yong Lo
  • Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
    Publication number: 20020098232
    Abstract: Novel pharmaceutical dosage forms provide for pulsatile delivery of an antiarrhythmic agent that releases the drug in spaced apart “pulses.” The dosage forms are comprised of first, second and optional third dosage units, with each dosage unit having a different drug release profile. The dosage forms may comprise capsules housing compressed tablets or drug-containing beads, granules, or particles or may comprise a single tablet with the first, second and optional third dosage units incorporated therein, or a “coated core” dosage form. Methods of treatment using the pharmaceutical dosage forms are provided as well.
    Type: Application
    Filed: August 14, 2001
    Publication date: July 25, 2002
    Inventors: Kamal K. Midha, Mark Hirsh, Whe-Yong Lo